Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 259.00
-0.90 (-0.35%)
Jul 17, 2026, 3:30 PM IST
Suraksha Diagnostic Revenue
In the fiscal year ending March 31, 2026, Suraksha Diagnostic had annual revenue of 3.10B INR with 23.13% growth. Suraksha Diagnostic had revenue of 814.12M in the quarter ending March 31, 2026, with 31.17% growth.
Revenue
3.10B
Revenue Growth
+23.13%
P/S Ratio
4.36
Revenue / Employee
2.39M
Employees
1,300
Market Cap
13.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.10B | 583.21M | 23.13% |
| Mar 31, 2025 | 2.52B | 333.84M | 15.26% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Windlas Biotech | 9.04B |
| GPT Healthcare | 4.73B |
| Tarsons Products | 4.23B |
| Accent Microcell | 3.50B |